Organon & Co
XMUN:7XP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Organon & Co
XMUN:7XP
|
US |
|
I
|
Ipopema Securities SA
WSE:IPE
|
PL |
|
S
|
Siam Wellness Group PCL
SET:SPA
|
TH |
|
Immobiliere Dassault SA
PAR:IMDA
|
FR |
|
E-L Financial Corp Ltd
TSX:ELF
|
CA |
|
P
|
Perak Transit Bhd
KLSE:PTRANS
|
MY |
|
Enefit Green AS
F:I6B
|
EE |
|
Advent Technologies Holdings Inc
NASDAQ:ADN
|
US |
|
A
|
Amyris Inc
F:3A01
|
US |
Wall Street
Price Targets
7XP Price Targets Summary
Organon & Co
According to Wall Street analysts, the average 1-year price target for
7XP
is 7.628 EUR
with a low forecast of 4.196 EUR and a high forecast of 10.47 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is 7XP's stock price target?
Price Target
7.628
EUR
According to Wall Street analysts, the average 1-year price target for
7XP
is 7.628 EUR
with a low forecast of 4.196 EUR and a high forecast of 10.47 EUR.
What is Organon & Co's Revenue forecast?
Projected CAGR
1%
For the last 7 years the
compound annual growth rate for
Organon & Co's revenue is
-6%.
The projected
CAGR
for the next 3 years is
1%.
What is Organon & Co's Operating Income forecast?
Projected CAGR
11%
For the last 7 years the
compound annual growth rate for
Organon & Co's operating income is
-10%.
The projected
CAGR
for the next 3 years is
11%.
What is Organon & Co's Net Income forecast?
Projected CAGR
80%
For the last 7 years the
compound annual growth rate for
Organon & Co's net income is
-29%.
The projected
CAGR
for the next 3 years is
80%.
